The Medicine Ma... How Advanced Therapy Manufacturing Can Be Augmented with Digital Transformation Interview
APM Health ‘Big hole’ for CDMOs in early cell and gene therapy space is adding to already soaring treatment costs – BioCentriq Executive Interview
Pluristyx BioCentriq Strengthens Partnership with Pluristyx to Accelerate the Development of iPSC-Derived NK Cell Therapies Partnerships
HOME